SCHEMBL7103710

SCHEMBL7103710

COC(=O)Cc1cc(C)c(-c2ccc(Cl)cc2)cc1C

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SUCNR1 Q9BXA5 1/20 0.43
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42
ALDH1A1 P00352 3/20 0.41
ACLY P53396 1/20 0.40
AKR1C3 P42330 1/20 0.40
KDM4E B2RXH2 2/20 0.40
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
PDGFRA P16234 1/20 0.39
FLT1 P17948 1/20 0.39
FGFR3 P22607 1/20 0.39
KDR P35968 1/20 0.39
EGLN1 Q9GZT9 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14089365 0.94 SUCNR1 (0.43) SUCNR1SLC6A4SLC6A3ALDH1A1ACLY
SCHEMBL7102760 0.85 SUCNR1 (0.43) SUCNR1SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL5535142 0.82 ACLY (0.47) SUCNR1ALDH1A1ACLYAKR1C3KDM4E
SCHEMBL7104011 0.81 CNR1 (0.36) SUCNR1SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL13136741 0.79 ALDH1A1 (0.49) ALDH1A1AKR1C3MAPTMAPK1
SCHEMBL10923842 0.79 ALDH1A1 (0.50) ALDH1A1ACLYAKR1C3KDM4EPDGFRB
SCHEMBL14616505 0.78 SUCNR1 (0.43) SUCNR1SLC6A4SLC6A3ALDH1A1KDM4E
SCHEMBL2352721 0.78 SUCNR1 (0.54) SUCNR1ALDH1A1KDM4ESLC1A3SLC1A2
SCHEMBL14432236 0.77 CA12 (0.46) ALDH1A1KDM4EPDGFRBFGFR1PDGFRA
SCHEMBL769393 0.76 PDGFRB (0.50) ALDH1A1KDM4EPDGFRBFGFR1PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-05-22 US disclosed
US-6451843-B1 Arylphenyl-substituted cyclic keto enols BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, SULT1E1 SUCNR1 4087/4885SLC6A4 3161/4885SLC6A3 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.